Neoprofen and Micafungin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Neoprofen (ibuprofen lysine) and Micafungin (micafungin sodium). Common drug interactions include chronic respiratory disease among females and intraventricular haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Neoprofen and Micafungin. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Neoprofen?

Neoprofen has active ingredients of ibuprofen lysine. eHealthMe is studying from 509 Neoprofen users. Check the latest studies of Neoprofen.

What is Micafungin?

Micafungin has active ingredients of micafungin sodium. eHealthMe is studying from 6,562 Micafungin users. Check the latest studies of Micafungin.



On Jul, 12, 2026

17 people who take Neoprofen and Micafungin together, and have interactions are studied.

Neoprofen and Micafungin drug interactions.

What are the common drug interactions of Neoprofen and Micafungin, by gender? *:

female:

  1. Chronic respiratory disease
  2. Coagulation factor decreased (less clotting substance in blood)
  3. Hyperglycaemia (high blood sugar)
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  5. Urine output decreased
  6. Bradycardia (abnormally slow heart action)
  7. Haemorrhage intracranial (bleeding within the skull)
  8. Renal disorder (kidney disease)
  9. Abdominal distension
  10. Blood creatinine increased

male:

  1. Intraventricular haemorrhage (intraventricular bleeding)
  2. Bilirubin conjugated increased
  3. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  4. Platelet count decreased
  5. Pulmonary haemorrhage (acute bleeding from the lung)
  6. Renal disorder (kidney disease)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Haematochezia (passage of stools containing blood)
  9. Inguinal hernia (hernia in which a loop of intestine enters the inguinal canal; the most common type of hernia in males)
  10. Lung disorder (lung disease)

What are the common drug interactions of Neoprofen and Micafungin, by age (0-1 to 60+)? *:

0-1:

  1. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  2. Intraventricular haemorrhage (intraventricular bleeding)
  3. Urine output decreased
  4. Blood creatinine increased
  5. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  6. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  7. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  8. Platelet count decreased
  9. Pulmonary haemorrhage (acute bleeding from the lung)
  10. Renal disorder (kidney disease)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Circulatory Collapse: 6 people, 35.29%
  2. Hypotension (abnormally low blood pressure): 6 people, 35.29%
  3. Intrauterine Infection: 4 people, 23.53%
  4. Haemorrhage Intracranial (bleeding within the skull): 4 people, 23.53%
  5. Intraventricular Haemorrhage (intraventricular bleeding): 4 people, 23.53%
  6. Respiratory Distress Syndrome (Rds) In Infants (respiratory disease of newborn babies, especially premature babies, characterized by distressful breathing, cyanosis, and the formation of a glassy membrane over the alveoli of the lungs): 3 people, 17.65%
  7. Lung Disorder (lung disease): 3 people, 17.65%
  8. Hypocalcaemia (levels of calcium in blood serum are abnormally low): 3 people, 17.65%
  9. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 3 people, 17.65%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 17.65%

* Approximation only. Some reports may have incomplete information.

Do you take Neoprofen and Micafungin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Neoprofen and Micafungin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Neoprofen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Micafungin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Neoprofen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Micafungin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen lysine and micafungin sodium (the active ingredients of Neoprofen and Micafungin, respectively), and Neoprofen and Micafungin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: